Supplementary Figure S7 from the Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab Plus Chemotherapy in Triple-Negative Breast Cancer

Supplementary Figure 7. Association of TNBC subtypes and IO classifications. A) Frequency of RT-qPCR DetermaIO class by TNBC subtype; B) Frequency of RNAseq IO classes by TNBC subtype. C) Multivariable logistic regression model with TNBC subtypes and RT-qPCR IO score for association with pCR by treatment arm. Odds ratio (OR) and 95% confidence intervals are shown. D) Multivariable logistic regression model with TNBC subtypes and RNA-Seq IO score for association with pCR by treatment arm. Odds ratio (OR) and 95% confidence intervals are shown.